Nasonex vs Telfast
A side-by-side look at two allergy medications advertised on TV. Informational only — not medical advice.
| NZ Nasonex | NZ Telfast | |
|---|---|---|
| Generic name | mometasone | fexofenadine |
| Drug class | Corticosteroid | Second-Generation Antihistamine |
| Treats | Allergic rhinitis, hay fever, nasal polyps | Hay fever, allergic rhinitis, hives |
| Category | Allergy | Allergy |
| Manufacturer | Organon | Sanofi |
| Year approved | 1997 | 1996 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $8M | $4M |
| Common side effects | Nosebleeds, Nasal irritation, Headache, Throat irritation | Headache, Nausea, Dizziness, Drowsiness (uncommon) |
Frequently asked questions
Is Nasonex or Telfast better?
Neither is universally "better." Nasonex (mometasone) and Telfast (fexofenadine) are both used for allergy, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Nasonex and Telfast?
Nasonex is a Corticosteroid made by Organon, while Telfast is a Second-Generation Antihistamine made by Sanofi. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Nasonex has the larger estimated TV advertising budget of the two.